Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
TipRanksMar 26 06:17 ET
ZyVersa Therapeutics Analyst Ratings
BenzingaMar 26 06:15 ET
Zyversa Therapeutics' 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
TipRanksMar 26 02:00 ET
ZyVersa Therapeutics Analyst Ratings
BenzingaMar 12 08:22 ET
Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)
TipRanksMar 12 06:30 ET
Buy Rating Affirmed for ZyVersa Therapeutics Amid Promising Inflammatory and Metabolic Syndrome Treatments
TipRanksFeb 29 06:46 ET
HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5
BenzingaSep 8, 2023 06:59 ET
ZyVersa Therapeutics Analyst Ratings
BenzingaSep 8, 2023 06:58 ET
Analysts Offer Insights on Healthcare Companies: ZyVersa Therapeutics (ZVSA), Halozyme (HALO) and Nurix Therapeutics (NRIX)
TipRanksSep 8, 2023 06:20 ET
No Data
No Data